ALDH1L2 orchestrates redox–growth coupling in renal carcinoma: pan-cancer evidence and mechanistic validation of the ROS–Akt/mTOR/S6K axis
BackgroundAldehyde dehydrogenase family 1 member L2 (ALDH1L2) has been relatively understudied in cancer. We aimed to systematically characterize its expression patterns, clinical significance, and potential functions across cancers and to validate its…